SCIMP Antibody, anti-human, REAfinity™
Synonyms: C17orf87
RECOMBINANT
Clone:
REA1292 | NVL-07
Type of antibody:
Primary antibodies, Recombinant antibodies
Isotype:
recombinant human IgG1
Applications:
ICFC Glossary
External link icon
Select a conjugate:
Select a size:
Other sizes

Related products for SCIMP Antibody, anti-human, REAfinity™

Intracellular flow cytometry applications
APC
PE
Species tested:
human
Recommended dilution:
1:50
Remark:
The antibody is suited for staining of formaldehyde-fixed cells.
Data source:
Miltenyi Biotec
Conjugate:
APC
Used products:
130-127-089, 130-127-104
Description:
Human peripheral blood mononuclear cells (PBMCs) were fixed and permeabilized using the FoxP3 Staining Buffer Set followed by intracellular staining with Anti-SCIMP antibodies or with the corresponding REA control (I) antibodies (left image) and HLA-DR,DP,DQ antibodies. Cells were then analyzed with the MACSQuant® Analyzer. Cell debris and dead cells were excluded from the analysis based on scatter signals.

Application imageView details view details

Application imageView details view details
Specifications for SCIMP Antibody, anti-human, REAfinity™
Overview

Clone REA1292 recognizes the human SCIMP, a membrane protein, which belongs to family of transmembrane adaptor proteins (TRAP). In a phosphorylated state, SCIMP binds to SLP65/SLP76 and inhibitory kinase Csk. It is expressed in antigen presenting cells (APC), including B cells, macrophages, and bone marrow derived dendritic cells. It may play a role in signal transduction after MHC-II stimulation and functions as a regulator of antigen presentation and other functions of antigen presenting cells.

Additional information: Clone REA1292 displays negligible binding to Fc receptors.

Alternative names

C17orf87

Detailed product information

Technical specifications

Clone
REA1292
Clonality
monoclonal
Isotype
recombinant human IgG1
Isotype control
REA Control Antibody (I), human IgG1
Host
human cell line
Type of antibody
Primary antibodies, Recombinant antibodies
Species reactivity
human
Antigen
SCIMP
Distribution of antigen
B cells, macrophages, dendritic cells

Recombinant antibodies at Miltenyi Biotec

As an innovation-powered company with a commitment to quality and excellence, Miltenyi Biotec applies cutting-edge methods to discover and develop newer and better antibodies to satisfy both market demand and regulatory requirements.

The Miltenyi way of generating best-in-class antibodies and antibody conjugates

At Miltenyi Biotec, we opt for recombinant antibodies, which enable sequence verification and optimization for lot-to-lot consistency, making them superior to hybridoma-based antibodies.

Infusing our unique expertise

Recombinants are the result of combining genetic material from different immunized animals, and using display technologies to screen in-house antibody libraries for the best antibodies. Additional analyses on existing hybridoma-based antibodies can also give rise to sequences contributing to novel recombinants.

Maximizing value for your research

By further re-engineering these antibody sequences, we can precisely control their properties to achieve the following benefits:

reduce undesirable binding to Fc gamma receptors,

  • eliminate destabilizing amino acid motifs,
  • increase specific bonding affinity for stronger, more accurate targeting, and
  • optimize fluorochrome conjugation for brighter and clearer signals.

In a final step, by synthesizing and cloning the resulting gene sequence, we achieve an expression vector that develops a cell line, which in turn produces a special recombinant antibody.

Better science with quality antibodies

Already in 2015, 100 of the world’s leading scientists collectively called for better standards and reproducibility in antibody production, proposing recombinant antibodies to circumvent variability (Baker, M. Reproducibility crisis: Blame it on the antibodies. Nature 521, 274–276 (2015). https://doi.org/10.1038/521274a). Moreover, by applying reverse engineering, which is encouraged by the EU Directive 2016/943 r, Miltenyi Biotec acts “[i]n the interest of innovation and fostering competition…” (§16).

Resources for SCIMP Antibody, anti-human, REAfinity™
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support

Citations for SCIMP Antibody, anti-human, REAfinity™
Publications
  1. Williamson, M. P. (1994) The structure and function of proline-rich regions in proteins. Biochem. J. 297 (2): 249-260
  2. Draber, P. et al. (2011) SCIMP, a transmembrane adaptor protein involved in major histocompatibility complex class II signaling. Mol. Cell. Biol. 31 (22): 4550-4562

You have previously chosen International as your location.
What do you want to do?